⌘K

Login Start Free

Home/Filings/4/0001415889-23-002466

4//SEC Filing

Teufel Crispin 4

Accession 0001415889-23-002466

CIK 0001600132other

View on SEC.gov Company Profile

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:48 PM ET

Size

5.2 KB

Accession

0001415889-23-002466

Insider Transaction Report

Form 4

Period: 2023-02-10

Bellerophon Therapeutics, Inc.BLPH

Director

Transactions

Award
Stock Options (right to buy)
2023-02-10$1.52/sh+29,000$44,080→ 29,000 total
Exercise: $1.52From: 2024-02-10Exp: 2033-02-10→ Common Stock (29,000 underlying)

Documents

1 file

4
form4-02142023_090243.xmlPrimary

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1

filerCIK 0001771517

Filing Metadata

Form type: 4
Filed: Feb 13, 7:00 PM ET
Accepted: Feb 14, 4:48 PM ET
Size: 5.2 KB

View on SEC.gov